Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(66.7%)
Phase 4
2(33.3%)
6Total
N/A(4)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06282510Phase 4Recruiting

Nasal Antisepsis for C. Auris Prevention

Role: collaborator

NCT05781243Phase 4Completed

Normal Saline Versus Lactated Ringer's Solution for Acute Pancreatitis Resuscitation

Role: collaborator

NCT02224352Not ApplicableUnknown

VentFree: A Novel Abdominal Stimulator to Assist With Ventilator Weaning

Role: collaborator

NCT02847988Not ApplicableUnknown

Facilitating Functional Independence in Patients Receiving Prolonged Mechanical Ventilation

Role: lead

NCT01825135Not ApplicableCompleted

Electrical Stimulation to Strengthen Muscles in the Lower Legs in Patients Requiring Prolonged Mechanical Ventilation

Role: lead

NCT01541462Not ApplicableCompleted

Weaning From Prolonged Mechanical Ventilation

Role: lead

All 6 trials loaded